CME Credit Available:

This activity offers .5 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Discuss criteria for the diagnosis and staging of chronic kidney disease (CKD) and examine real-world practices for CKD screening and monitoring.
• Review the current recommendations for the assessment of kidney function.
• Describe methods for prognostication in both early and advanced CKD.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Tarra Faulk, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from January 14, 2024, until January 14, 2027.

CME Credit Available:

This activity offers 1.5 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Discuss the healthcare implications of domestic violence.
• Effectively screen for domestic violence.
• Discuss appropriate documentation in cases of suspected domestic violence.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Rashard Perry, faculty for this activity, has no relevant relationships with ineligible companies to disclose.

Markos Fleury, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from January 14, 2024, until January 14, 2027.

CME Credit Available:

This activity offers .75 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• To understand the treatment as prevention.
• To understand post-exposure prophylaxis.
• To understand pre-exposure prophylaxis.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Erik D. Wert, DO, FACOI, has disclosed the following financial relationships:

• Gilead Pharmaceuticals - NOVA Grant - Studying PrEP in the BDSM/Kink Community
• Speaker TASHRA    

Release & Review Date: 

This activity is valid from January 14, 2024, until January 14, 2027.

CME Credit Available:

This activity offers 1 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Define sex trafficking and labor trafficking.
• Identify individuals who may be victims of human trafficking accessing health care.
• Prepare providers to respond to victims of human trafficking using a trauma-informed approach.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Matt Tyler and Marcos Fleury, faculty for this activity, have no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from January 14, 2024, until January 14, 2027.

CME Credit Available:

This activity offers .75 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Define palliative care in the context of cancer, citing the World Health Organization's official definition.
• Discuss the importance of early integration of palliative care in patients with advanced cancer diagnoses.
• Examine the guidelines and recommendations for integrating palliative care into standard oncology care, as presented by the American Society of Clinical Oncology and the National Comprehensive Cancer Network.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Jason R. Beckrow, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from January 14, 2024, until January 14, 2027.

CME Credit Available:

This activity offers .75 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Have a comprehensive understanding of DoxyPep.
• Explain PEPFAR.
• Articulate how Hansen's disease is endemic in Central Florida.
• Evaluate how climate change in 2023 is responsible for an increase in the incidence of number of infectious diseases such as babesiosis, dengue fever, malaria, and alpha gal syndrome.
• Recognize that HPAI H5N1 has the potential to become an epidemic.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. MarkAlain Dery, DO, MPH, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from January 14, 2024, until January 14, 2027.

CME Credit Available:

This activity offers 1.25 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• To highlight the significant need for menopause education.
• Highlight the prevalence of anxiety and depression menopause.
• Point out disparities in menopausal mental health care.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Machelle M. Seibel, MD, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Dr. Verna Brooks McKenzie, MB, BS, DGO, DM (O&G), NCMP, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Dr. Karen Giblin, MS, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from January 14, 2024, until January 14, 2027.

CME Credit Available:

This activity offers .75 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Discuss 2 skills in building a foundation of trust with patients by increasing our listening skills.
• Identify 2 risk factors in preventing a crisis through whole-patient-centered care.
• Identify 3 tools that aid in caregiver support.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Sandra P. Gomez, MD, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from January 14, 2024, until January 14, 2027.

CME Credit Available:

This activity offers 2.0 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• Understand the pharmacology of the opioid class of analgesics.
• Explain the epidemiology, incidence, and impact of the opioid epidemic.
• Describe the current Florida law regarding the prescribing of opioids.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Joshua D. Lenchus, DO, faculty for this activity, has disclosed the following financial relationships: 

• Consulting Fee - Consultant - Medline Industries, Inc.
• Stock Options - Consultant - Vave Health

Release & Review Date: 

This activity is valid from January 14, 2024, until January 14, 2027.

CME Credit Available:

This activity offers .75 1A AOA 

Note: ACOI reports credits to the AOA after the end of each quarter.

Learning Objectives:

In this session, you'll learn how to:

• To understand what the responsibilities physicians have with regard to their colleagues being impaired.
• Lay out generally accepted practice in the approach to suspected impairment of physicians in the clinical setting.
• Clearly delineate the rights of the physician suspected of impairment and the process of aiding them into recovery.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Dr. Thomas F. Jan, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from January 14, 2024, until January 14, 2027.